Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
02 2021
Historique:
received: 26 05 2020
revised: 31 08 2020
accepted: 08 10 2020
pubmed: 18 10 2020
medline: 15 9 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

To develop methods guidance to support the conduct of rapid reviews (RRs) produced within Cochrane and beyond, in response to requests for timely evidence syntheses for decision-making purposes including urgent health issues of high priority. Interim recommendations were informed by a scoping review of the underlying evidence, primary methods studies conducted, and a survey sent to 119 representatives from 20 Cochrane entities, who were asked to rate and rank RR methods across stages of review conduct. Discussions among those with expertise in RR methods further informed the list of recommendations with accompanying rationales provided. Based on survey results from 63 respondents (53% response rate), 26 RR methods recommendations are presented for which there was a high or moderate level of agreement or scored highest in the absence of such agreement. Where possible, how recommendations align with Cochrane methods guidance for systematic reviews is highlighted. The Cochrane Rapid Reviews Methods Group offers new, interim guidance to support the conduct of RRs. Because best practice is limited by the lack of currently available evidence for some RR methods shortcuts taken, this guidance will need to be updated as additional abbreviated methods are evaluated.

Identifiants

pubmed: 33068715
pii: S0895-4356(20)31146-X
doi: 10.1016/j.jclinepi.2020.10.007
pmc: PMC7557165
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Chantelle Garritty (C)

Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Canada; TRIBE Graduate Program, University of Split School of Medicine, Croatia. Electronic address: cgarritty@ohri.ca.

Gerald Gartlehner (G)

Cochrane Austria, Danube University Krems, Krems a.d. Donau, Austria; RTI International, Research Triangle Park, NC, USA.

Barbara Nussbaumer-Streit (B)

Cochrane Austria, Danube University Krems, Krems a.d. Donau, Austria.

Valerie J King (VJ)

The Center for Evidence-based Policy, Oregon Health & Science University, Portland, OR, USA.

Candyce Hamel (C)

Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Canada; TRIBE Graduate Program, University of Split School of Medicine, Croatia.

Chris Kamel (C)

CADTH, Ottawa, ON, Canada.

Lisa Affengruber (L)

Cochrane Austria, Danube University Krems, Krems a.d. Donau, Austria.

Adrienne Stevens (A)

Cochrane Canada, McMaster University, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH